Sign In
Last checked at 
23 Mar 2018 15:25
Surgical Innovations Group plc
("SI Group" or "the Company")
Director/PDMR Shareholding
The Company was notified on 23 March 2018 that on 22 March 2018 Melanie Ross, Chief Operating Officer, purchased 483,998 ordinary shares of 1 penny each in the Company ("Shares") for her ISA and her husband, Lee Ross purchased 483,998 Shares for his ISA, both at a price of 3.753p per share. To facilitate these purchases, also on 22 March 2018, Melanie Ross sold 967,996 Shares at a price of 3.75p each.
In addition, on 23 March 2018 Melanie Ross purchased 504,644 Shares at a price of 3.57p per share in an off-market transaction from Hardy Transaction Management Limited, which is wholly owned by Paul Hardy, a Non-Executive Director of the Company.
Following the transactions, the combined beneficial holding of Melanie Ross and her husband in the Company is 2,078,354 Shares, representing approximately 0.27% of the issued share capital and the beneficial holding of Paul Hardy is 6,225,541 Shares, representing 0.80% of the issued share capital.
For further information please contact:
Surgical Innovations Group Plc | www.sigroupplc.com | |
Nigel Rogers, Executive Chairman | Tel: 0113 230 7597 | |
Melanie Ross, COO & Finance Director | ||
WH Ireland Limited (NOMAD & Broker) | ||
Tim Feather / Alex Bond
| Tel: 0113 394 6600
| |
Walbrook PR (Financial PR & Investor Relations) | Tel: 020 7933 8780 or si@walbrookpr.com | |
Paul McManus | Mob: 07980 541 893 | |
1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
a) | Name | Melanie Ross | |||
2 | Reason for the notification | ||||
a) | Position/status | Chief Operating Officer, Surgical Innovations Group plc | |||
b) | Initial notification/ Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Surgical Innovations Group plc | |||
b) | LEI | 2138004GHGUH3HUZE156 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704 | |||
b) | Nature of the transactions | Sale of Ordinary Shares | |||
c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
3.75p | 967,996 | ||||
d) | Aggregated information - Aggregated volume - Price |
967,996 £36,300 | |||
e) | Date of the transaction | 22 March 2018
| |||
f) | Place of the transaction | London Stock Exchange, AIM
| |||
1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
a) | Name | Melanie Ross | |||
2 | Reason for the notification | ||||
a) | Position/status | Chief Operating Officer, Surgical Innovations Group plc | |||
b) | Initial notification/ Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Surgical Innovations Group plc | |||
b) | LEI | 2138004GHGUH3HUZE156 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704 | |||
b) | Nature of the transactions | 1. Purchase of shares in ISA 2. Purchase of shares by husband 3. Purchase of shares | |||
5. | Price(s) and volume(s) | Price(s) | Volume(s) | ||
3.75p | 483,998 | ||||
3.75p | 483,998 | ||||
3.57p | 504,644 | ||||
d) | Aggregated information - Aggregated volume - Price |
1,472,640 £54,316 | |||
e) | Date of the transaction | 1. & 2. - 22 March 2018 3.- 23 March 2018 | |||
f) | Place of the transaction | 1. & 2. - London Stock Exchange, AIM 3. - Off market | |||
1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
a) | Name | Paul Hardy | |||
2 | Reason for the notification | ||||
a) | Position/status | Non-Executive Director, Surgical Innovations Group plc | |||
b) | Initial notification/ Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Surgical Innovations Group plc | |||
b) | LEI | 2138004GHGUH3HUZE156 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704 | |||
b) | Nature of the transactions | Sale of Ordinary Shares | |||
c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
3.57p | 504,644 | ||||
d) | Aggregated information - Aggregated volume - Price |
504,644 £18,016 | |||
e) | Date of the transaction | 23 March 2018 | |||
f) | Place of the transaction | Off market | |||
Follow the stocks
